Matthew L. Posard
CIK 1543792 · Chief Commercial Officer · last filed 2026-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.26M
Companies
6
Total Filings
39
Lifetime Open-Market Net
-$5.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTI | Director | 77,835 | — | — | -$4.40M | 16 | 2026-05-07 |
| NAUT | Director | 130,000 | $2.24 | $291.2K | $225.5K | 5 | 2025-06-25 |
| Talis Biomedical Corp (TLIS) Delisted | Director | 62,500 | $2.84 | $177.5K | $1.00M | 3 | 2023-06-12 |
| DermTech, Inc. (DMTK) Delisted | Director | 158,215 | $0.09 | $14.9K | $1000.0K | 8 | 2023-06-05 |
| Cardiff Oncology, Inc. (TROVW) Delisted | Chief Commercial Officer | — | — | — | $0 | 1 | 2016-01-06 |
| ILMN | Sr VP & General Manager | 30,858 | $160.97 | $4.97M | -$3.00M | 6 | 2013-05-30 |
Recent Filings · Page 4 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-06 | Cardiff Oncology, Inc. (TROVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-07 | HTI | Grant (A) | +13,175 | $0 | EDGAR |
| 2013-05-30 | ILMN | Mixed | — | -$95.7K | EDGAR |
| 2013-04-15 | ILMN | Mixed | — | -$1.33M | EDGAR |
| 2013-03-28 | HTI | Grant (A) | +20,000 | $0 | EDGAR |
| 2013-03-12 | ILMN | Tax (F) | −1,624 | -$87.3K | EDGAR |
| 2013-01-31 | ILMN | Mixed | +4,158 | -$15.2K | EDGAR |
| 2013-01-29 | ILMN | Tax (F) | −1,390 | -$71.8K | EDGAR |
| 2012-03-12 | ILMN | Grant (A) | +12,292 | $0 | EDGAR |
Showing 31–39 of 39
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.